Seminoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Heinrich-Heine University, Duesseldorf
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07498959	Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer(TESTIGO)	recruiting	N/A	160	Sahlgrenska University HospitalOTHER	1	Mar 27, 2026	clinicaltrials
NCT05345158	R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma	recruiting	N/A	25	University Health Network, TorontoOTHER	1	Dec 19, 2025	clinicaltrials